The Sentinel Initiative was launched in response to the Food and Drug Administration Amendments...

On February 8, 2019, the Duke-Margolis Center for Health Policy will bring together stakeholders...

The U.S. Food and Drug Administration (FDA) is announcing a public workshop entitled “Evaluating...

In the coming years, there will be emerging opportunities for making better use of real-world...

On December 3, 2018, in cooperative agreement with the U.S. Food and Drug Administration (FDA),...

Drug shortages complicate patient care and lead to adverse clinical consequences. They directly...

Value-based pricing has become a popular term for how healthcare pricing, particularly drug...

Over the last several years, clinician-scientists, regulators, advocates, and industry partners...

Convened by the Robert J. Margolis, MD, Center for Health Policy at Duke University, the Second...

Despite rising rates of Americans suffering from opioid addiction, millions of Americans still...